A scientist who studies how dopamine works in the brain will use a $400,000 grant to investigate clues that the chemical may have a role in Alzheimer’s disease. The information could be used to shut down the degenerative process at the beginning, before patients lose brain cells and memory they will never get back. “All therapeutic treatments (for Alzheimer’s) are symptomatic. They can’t slow down the disease,” said Michael Beckstead, who works in the Aging & Metabolism Research Program at the Oklahoma Medical Research Foundation. “Once brain cells are dead, they can’t come back,” Beckstead said. “If we catch it early on before the cells really start dying off, we could develop therapies to arrest the process in its earliest stages before any cognitive damage is done.” That will require a way to diagnose Alzheimer’s sooner because it usually isn’t diagnosed until memory loss has set in. Some of the earliest symptoms are depression and apathy, which involve areas of the brain Beckstead studies. “People with depression and apathy are much more likely to develop Alzheimer’s later in life,” he said. With the new grant from the National Institute on Aging, he will be studying dopamine neurons in the brains… Read full this story
- UW research investigates Huntington’s disease: Mouse models point to mitochondrial iron as factor
- At 12.5% Discount To NAV, Source Capital May Be Attractive To Investors Seeking A Balanced Fund - Source Capital (NYSE:SOR)
- Alzheimer’s disease researcher gets $10G from Bay Shore center
- Smartphone 'Scores' can Help Doctors Track Severity of Parkinson's Disease Symptoms
- New definition of Alzheimer’s changes how disease is researched
- Burden of patients with multiple diseases could sink health systems around the world, warn medical experts
- Inspiring Dundonian opens up about life with his terminal muscle-wasting disease – and how life has changed
- Research shows diabetes drug’s promise in zapping prostate cancer
- CRISPR: The gene-editing tool revolutionizing biomedical research
- Scientist Behind Dolly the Sheep, a Key to Parkinson’s Research, Has the Disease Himself
Researcher seeks to stop Alzeheimer's disease at its source have 351 words, post on oklahoman.com at July 14, 2019. This is cached page on USA Breaking News. If you want remove this page, please contact us.
